Fig. 3

Kaplan-Meier analysis of progression-free survival in second and third line treatment population (a) PFS in all patients (b) PFS in the primary resistant population
Kaplan-Meier analysis of progression-free survival in second and third line treatment population (a) PFS in all patients (b) PFS in the primary resistant population